Concepedia

Comparative Adverse Event Profiling

Comparative Adverse Event Profiling is a systematic methodological framework within pharmacovigilance and clinical research that characterizes and contrasts the safety profiles of two or more therapeutic interventions by quantitatively identifying, aggregating, and evaluating differential rates and patterns of adverse events across comparable patient populations.

33

Publications

1.3K

Citations

251

Authors

130

Institutions

Publications per year

2017–2026

21

Parents

Publications

33

Adverse Effects of Low-Dose Methotrexate

Daniel H. Solomon, Robert J. Glynn, Elizabeth W. Karlson et al. · Annals of Internal Medicine · 2020 · 222 citations · Full text

, , +13

A comparison of iatrogenic injury studies in Australia and the USA II: reviewer behaviour and quality of care

W. B. Runciman · International Journal for Quality in Health Care · 2000 · 119 citations · Full text

, , +15

Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials

Raj Tummala, Gabriel Abreu, Lilia Pineda et al. · Lupus Science & Medicine · 2021 · 92 citations · Full text

, , +17

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

Mark L. Hartman, Rong Xu, Brenda Crowe et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 88 citations · Full text

, , +13

Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system

Akiho Fukuda, Kohei Tahara, Yuuki Hane et al. · PLoS ONE · 2017 · 69 citations · Full text

, , +17

1–5 of 33

Authors

251

  1. YZ
    Yanbin Zeng

    Xiamen Maternal and Child Health Hospital, China

    1 publications · 33 citations

    1

    h-index

  2. CZ
    Cordula Zeller

    Boehringer Ingelheim (Germany), Germany

    1 publications · 11 citations

    1

    h-index

  3. LW
    Lizhu Weng

    Fujian Medical University, China

    1 publications · 33 citations

    1

    h-index

  4. JS
    Jackie Stratton

    Brigham and Women's Hospital, United States

    1 publications · 222 citations

    1

    h-index

  5. SP
    Sarah P. Hammond

    Harvard University, United States

    1 publications · 222 citations

    1

    h-index

1–5 of 251

Institutions

130

  1. Pfizer (United States)

    New York, United States

    4 h-index

    15 publications

    578 citations

  2. Harvard University

    Cambridge, United States

    2 h-index

    2 publications

    109 citations

  3. National Patient Safety Foundation

    Boston, United States

    2 h-index

    2 publications

    152 citations

  4. Icahn School of Medicine at Mount Sinai

    New York, United States

    2 h-index

    2 publications

    76 citations

  5. Karolinska University Hospital

    Stockholm, Sweden

    2 h-index

    2 publications

    44 citations

  6. The University of Texas Southwestern Medical Center

    Dallas, United States

    2 h-index

    3 publications

    147 citations

  7. Brigham and Women's Hospital

    Boston, United States

    2 h-index

    25 publications

    5.4K citations

  8. Massachusetts General Hospital

    Boston, United States

    2 h-index

    2 publications

    32 citations

1–8 of 130

Venues

  1. Journal of Oncology Pharmacy Practice

    2 publications · 28 citations

    2

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 21 citations

    1

    h-index

  3. Pharmaceutical Statistics

    1 publications · 17 citations

    1

    h-index

  4. Seminars in Arthritis and Rheumatism

    1 publications · 12 citations

    1

    h-index

  5. OncoTargets and Therapy

    1 publications · 10 citations

    1

    h-index

1–5